2015 News Releases

Keyword Search
 
2015 | 2014 | 2013 | 2012 | 2011
DateTitle 
03/17/15Entellus Medical Announces Fourth Quarter and Full Year 2014 Financial Results and Provides 2015 Financial Outlook
PLYMOUTH, Minn., March 17, 2015 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. ("Entellus Medical" or the "Company") (Nasdaq:ENTL), a medical technology company focused on the design, development and commercialization of products for the minimally invasive treatment of chronic and recurrent sinusitis patients in the physician office setting or operating room, today reported its financial results for the three months and year ended December 31, 2014. Recent Highlights and Accomplishments ... 
03/03/15Entellus Medical to Report Fourth Quarter and Full Year 2014 Financial Results on March 17, 2015
Conference Call Scheduled for Tuesday, March 17, 2015 at 4:30pm ET PLYMOUTH, Minn., March 3, 2015 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (Nasdaq:ENTL), a medical technology company focused on products for the minimally invasive treatment of chronic and recurrent sinusitis patients in the physician office setting or operating room, today announced that it will release its financial results for the fourth quarter and full year of 2014 after the close of trading on Tuesday, March 17, 2015. The... 
02/13/15Entellus Medical Announces Release of XprESS(TM) Ultra Multi-Sinus Dilation System
PLYMOUTH, Minn., Feb. 13, 2015 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (Nasdaq:ENTL), a medical technology company focused on products for the minimally invasive treatment of chronic and recurrent sinusitis patients in the physician office setting or operating room, today announced the release of the XprESS™ Ultra Multi-Sinus Dilation System, the third device in the XprESS family of balloon sinus dilation systems. XprESS Ultra provides the precision, versatility and control of the XprESS ... 
02/03/15Entellus Medical, Inc. Announces Closing of Initial Public Offering
PLYMOUTH, Minn., Feb. 3, 2015 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (Nasdaq:ENTL), a medical technology company focused on products for the minimally invasive treatment of chronic and recurrent sinusitis patients in the physician office setting or operating room, announced today the closing of its initial public offering of 5,294,117 shares of its common stock (including 690,537 shares purchased by the underwriters pursuant to an option to purchase additional shares) at a public offering pr... 
01/28/15Entellus Medical, Inc. Announces Pricing of Initial Public Offering
PLYMOUTH, Minn., Jan. 28, 2015 (GLOBE NEWSWIRE) -- Entellus Medical, Inc., a medical technology company focused on products for the minimally invasive treatment of chronic and recurrent sinusitis patients in the physician office setting or operating room, announced today the pricing of its initial public offering of 4,603,580 shares of its common stock at an initial public offering price of $17.00 per share, before underwriting discounts and commissions. The shares are expected to begin trading ...